Feasibility and efficacy of mitral repair in the elderly remain controversial. This study aims to compare outcomes of mitral repair and replacement in octogenarians.
Introduction
Mitral valve repair is the treatment of choice for severe mitral regurgitation in the general population, 1 as it has been demonstrated to provide a significant survival advantage over both medical treatment 2, 3 and mitral valve replacement. 4 The feasibility and efficacy of mitral repair in very elderly patients, however, are more controversial. 5 Over 80% of octogenarian patients with severe mitral regurgitation and class I indications for surgery are denied surgery, 6 and of those patients who do undergo surgery over two-thirds receive a mitral valve replacement. 7, 8 This reflects the perception that mitral valve surgery is associated with prohibitively high early mortality in this age group; second, the belief that the survival benefit associated with repair may not be applicable in elderly patients; and third, concerns that fragile tissues and valvular calcification are more likely to preclude satisfactory valve repair in older patients. Consequently, current consensus guidelines recommend medical management of severe mitral regurgitation in all except very symptomatic elderly patients. 1 Previous studies are limited by the small numbers of octogenarian patients undergoing mitral valve surgery in most institutions and consequently either include younger patients in their cohorts, 5,9 -12 or combine the results of mitral repair and replacement. 13, 14 This study was therefore designed to examine the feasibility and efficacy of routine mitral valve repair compared with mitral valve replacement in octogenarians, and to provide information on outcomes according to the aetiology of mitral regurgitation in this age group.
Methods

Study population
We retrospectively analysed 322 consecutive octogenarian patients who underwent mitral valve repair (n ¼ 227, 70%) or replacement (n ¼ Patients undergoing concomitant aortic valve replacement were excluded. The mean age of patients was 83 + 2 years, and 45.0% (n ¼ 132) of patients were female. Aetiology, documented in all patients, was degenerative disease in 44% (n ¼ 144); ischaemic in 24% (n ¼ 77); rheumatic in 11% (n ¼ 34); and endocarditis in 5% (n ¼ 17). The ascribed aetiology of the mitral regurgitation in the remaining 16% (n ¼ 50) was prosthetic valve failure, prosthetic valve endocarditis, failure of previous repair, mitral annular calcification, intra-cardiac mass, and dilated cardiomyopathy. Eight per cent of patients (n ¼ 25) had a pre-operative left ventricular ejection fraction of ,30%, and 11% (n ¼ 36) had undergone previous cardiac surgery. Patient demographics are summarized in Table 1 . Propensity scores were calculated for each patient to minimize treatment allocation bias. In order to compare the results of repair and replacement in a less heterogeneous patient group, we analysed the subgroup of elective octogenarians with degenerative disease ( Table 2) .
Definitions
Pre-operative co-morbidities were defined according to the definitions used in the EuroSCORE risk stratification model. 15 Post-operative respiratory failure was defined as re-intubation or total intubation .72 h; post-operative renal failure was defined as new dialysis requirement or creatinine .2.5 mg/dL for 7 days post-operatively; post-operative stroke was defined as new, permanent neurological disability; and postoperative gastrointestinal complication was defined as upper or lower gastrointestinal bleeding or need for surgical intervention. Valve aetiology and lesions were determined by the surgeon after intra-operative inspection of the valve. Degenerative disease was defined as single-or multi-segment prolapse due to chordal elongation or rupture. Ischaemic mitral regurgitation was caused by papillary muscle displacement posteriorly as a result of asymmetrical left ventricular dilatation due to ischaemic cardiomyopathy. Rheumatic valve disease was defined as reduced leaflet motion in systole and diastole associated with leaflet thickening and commissural fusion. Endocarditis was defined by the evidence of acute or chronic vegetations or leaflet perforation, or a history of endocarditis. Emergency surgery was defined as surgery carried out within 24 h of unscheduled admission, and included patients presenting with acute decompensation of chronic mitral regurgitation and mechanical complications of acute myocardial infarction and endocarditis.
Intra-operative management
Incisions included sternotomy, lower hemisternotomy, conventional thoracotomy, and non-rib-spreading mini-thoracotomy approaches. The choice of incision was dependent on centre and surgeon preference. Patients undergoing sternotomy approaches were cannulated in the ascending aorta and in both venae cavae unless epiaortic scanning revealed significant atherosclerotic disease, in which case the right axillary artery was typically cannulated. Patients undergoing nonsternotomy approaches were usually cannulated via the right femoral artery and vein. Techniques of myocardial protection used included high-potassium antegrade and retrograde cold blood cardioplegia, high-potassium antegrade cold crystalloid cardioplegia, and fibrillatory arrest without cross-clamping, also according to surgeon or centre preference. Further myocardial protection was obtained with moderate systemic cooling (28 -308C). In re-operative cases with patent left internal mammary artery grafts, patients were cooled to a systemic temperature of 20 -258C, and cardioplegia was given in a retrograde and antegrade fashion intermittently. Decisions regarding repair or replacement as well as prosthesis choice were made according to surgeon preference. In both centres, repair was favoured wherever technically possible: relative contraindications to repair included extensive leaflet calcification or destruction, excessive leaflet tethering in severe ischaemic cardiomyopathy, and significant mitral stenosis. The repair techniques employed have been described previously. 16 -18 Two main approaches were employed in degenerative disease. The first approach used classic Carpentier technique based primarily on leaflet resection, leaflet resuspension with native chordae, and a truesized annuloplasty using a complete semi-rigid remodelling ring. The second approach involved suturing pre-formed polytetrafluorethylene neo-chordae to the papillary muscles and all prolapsing segments, followed by a remodelling annuloplasty. The primary approach to ischaemic disease was a down-sized annuloplasty using a complete semi-rigid remodelling ring. Concomitant coronary bypass grafting was generally not performed on vessels with patent stents, where there was no evidence of reversible ischaemia, or where target vessels were occluded or too small to graft. In acute bacterial endocarditis, all infected material was debrided, and valve reconstruction performed using a lesion-specific approach, including the use of glutaraldehyde-treated autologous pericardium to reconstitute leaflet tissue and support annuloplasty where appropriate. In rheumatic disease, fused commissures and restrictive chordae were divided, and glutaraldehyde-treated autologous pericardium patch augmentation performed. All but one replacement were performed using bioprosthetic valves, using a subvalvular sparing technique wherever possible. Adjunctive cardiac procedures (Table 1) , including coronary artery bypass grafting (CABG) and atrial ablation procedures, were carried out in patients prior to the mitral procedure, whereas tricuspid valve repair was generally carried out after the mitral procedure. Intra-operative transoesophageal echocardiography was performed prior to the institution of, and following weaning from, cardiopulmonary bypass.
Data collection and follow-up
Clinical variables were prospectively entered into databases including patient demographics and risk factors, operative information, and postoperative outcome data. Additional information was obtained from patient charts when necessary. Mean follow-up time was 2.4 + 2.3 years (range 0.5 -8.3 years). The main outcome of interest was 30-day mortality. Other outcomes analysed included 90-day mortality, residual mitral regurgitation, major post-operative complications, and survival. Follow-up survival information for US patients was obtained by cross-matching each patient's social security number with the webbased social security death index (http://ssdi.rootsweb.com/) in January 2009. For German patients, government death registries were examined and patients' general practitioners were contacted. Table 1 summarizes pre-operative variables included in this study. The logistic EuroSCORE 15 was used for risk stratification.
Data analyses
Continuous variables are expressed as mean + standard deviation. Categorical variables are presented as percentages. Differences between groups were assessed with the x 2 or Fisher's exact test for categorical variables, the unpaired Student's t-test for normally distributed continuous variables, and the Mann-Whitney U test for nonnormally distributed continuous variables. Tests were two-tailed. Logistic regression was used to evaluate correlates of replacement vs. repair. Mid-term survival was evaluated with Kaplan-Meier survival analysis and log-rank test. A Cox proportional hazard regression was performed to determine independent predictors of mortality in univariate and multivariate analyses. Additionally, univariate and multivariate logistic regression models were utilized to identify predictors of operative mortality and major post-operative morbidity. Results are demonstrated as hazard ratio (HR) or odds ratio (OR) and 95% confidence intervals (CIs). A P-value ,0.05 was considered statistically significant.
In a separate analysis, we calculated the propensity to undergo mitral valve replacement using multivariable logistic regression to model a dichotomous outcome of replacement or repair for 263 patients in the sample. Patients undergoing re-replacement were excluded from the propensity score analysis. Sixteen fixed effect variables were included in the final model. power were validated with the Hosmer and Lemeshow goodness-of-fit test (P ¼ 0.97) and c statistic (0.88), respectively. The impact of mitral valve replacement on mid-term survival and post-operative morbidity and mortality was adjusted for propensity score by inclusion in the model as a covariate. The statistical analysis was performed using SPSS for Windows, version 17.0 (SPSS, Inc., Chicago, IL, USA).
Results
Baseline patient demographics, risk variables, and co-morbidity are summarized in Table 1 . Adjustment for propensity score yielded two treatment groups with no significant difference in baseline characteristics ( Table 1 ). In the subgroup of octogenarians undergoing elective surgery for degenerative disease, pre-operative patient characteristics were not significantly different between patients undergoing repair and replacement, with the exception of a higher incidence of pre-operative renal failure in patients undergoing replacement, resulting in a higher mean logistic Euro-SCORE in the replacement group ( Table 2) .
Operative procedures
Adjunctive cardiac procedures are summarized in Table 1) . Twenty-five per cent of patients (n ¼ 79) underwent non-rib-spreading mini-thoracotomy approaches and there was no significant difference in the rate of repair between these patients and those undergoing conventional approaches. Institution was a significant predictor of replacement in the overall patient cohort, and when only elective patients with degenerative disease were analysed ( Table 3) .
Outcomes
Overall early mortality and morbidity are shown in Table 4 , and were not significantly different between the two institutions. Mitral valve replacement was associated with significantly higher operative mortality than mitral repair in the overall patient group as well as after adjustment for propensity score ( Mitral surgery in octogenarians 95% CI 1.1 -5.9, P ¼ 0.032) and mitral replacement (HR 2.5, 95% CI 1.0 -6.0, P ¼ 0.045).
Gastrointestinal complications occurred more frequently in patients undergoing replacement compared with repair both in the overall group and after propensity score adjustment. Otherwise major early post-operative morbidity did not differ between repair and replacement groups. The overall incidence of postoperative stroke was 2% (n ¼ 8) ( Table 4) .
Pre-discharge trans-thoracic echocardiographic assessment was available in 264 (72%) patients. In patients who underwent repair, pre-discharge echocardiography showed no, trace, or mild mitral regurgitation in 99% (n ¼ 263) patients ( Table 5) .
Adjusted survival was significantly better in patients who had undergone repair (Figure 1) . Survival was also significantly better in elective degenerative patients undergoing mitral repair compared with replacement ( Figure 2) . Concomitant CABG was associated with greatly increased early mortality and a significant reduction in survival at 5 years (Figure 3) , and less than half of patients with ischaemic mitral regurgitation and severe left ventricular dysfunction survived to 1 year in either group. Multivariate analysis performed on all patients identified several independent risk factors for decreased survival including an ejection fraction ≤30% (HR 1.8, 95% CI 1.0 -3.3, P ¼ 0.047), renal failure (HR 1.8, 95% CI 1.1 -2.8, P ¼ 0.02), and emergency surgery (HR 2.9, 95% CI 1. included in the multivariate analysis, age (HR 1.1, 95% CI 1.0-1.2, P ¼ 0.02) and mitral valve replacement (HR 1.6, 95% CI 1.0 -2.4, P ¼ 0.043) were identified as the only independent predictors of worse survival. Concomitant coronary surgery was not found to be predictive of decreased survival in multivariate analysis.
Discussion
The main findings of this study are that isolated primary elective mitral valve repair can be undertaken in selected octogenarians with degenerative mitral regurgitation, low operative mortality and morbidity, and minimal residual or recurrent mitral regurgitation. Early mortality appears, however, to be relatively high in the general population of octogenarians undergoing mitral surgery, particularly those requiring concomitant CABG, mitral valve replacement, or emergency surgery. Mid-term survival in elderly patients who undergo mitral repair appears to be significantly better than that of patients undergoing replacement. The American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of the general populace of severe mitral regurgitation recommend medical management of all but very symptomatic mitral regurgitation in elderly patients. 1 The higher threshold for surgery, compared with younger patients where surgical referral before symptom onset is recommended for patients with left ventricular dysfunction, atrial fibrillation, or pulmonary artery hypertension, stems in part from reports of high operative mortality in elderly patients. The operative mortality, for example, in a cohort of 2700 octogenarian patients undergoing mitral valve replacement between 1997 and 2000 from the Society of Thoracic Surgeons National Cardiac Database was 16.9%. 19 In smaller single-centre studies, operative mortality has ranged from 15 to 20%, 14, 19 which is similar to what we observed in our overall cohort. Much lower operative mortality, however, has been reported in elderly patients with non-ischaemic mitral regurgitation undergoing isolated mitral surgery similar to that reported here. 13 In contrast to encouraging outcomes in elective patients with degenerative disease, we identified two main subgroups at particular risk of poor outcomes with mitral surgery. Mitral regurgitation due to ischaemic cardiomyopathy is associated with a much poorer operative outcome and long-term prognosis than degenerative mitral regurgitation, 20 and in very elderly patients with ischaemic Figure 1 Kaplan-Meier actuarial survival curve for all patients according to whether they underwent mitral valve repair or replacement.
mitral regurgitation, the operative mortality has been reported to be .15%. 19, 21 In contrast with degenerative patients who required concomitant CABG (a significant proportion as might be expected in such an elderly population), patients with mitral regurgitation due to severe ischaemic cardiomyopathy faired very poorly, with less than half surviving to 1 year. Although these patients with NYHA class III/IV symptoms of heart failure and decreased left ventricular function pre-operatively represent a subgroup very likely to die in the short-term without surgery, there may be little grounds to offer surgery to improve life expectancy on the basis of the figures for survival presented here: maximal medical therapy is most probably the treatment of choice. We also found emergency presentation to be a particularly strong risk factor for early and later mortality in this patient cohort, confirming previous findings, 22 and underlining the need to follow disease progression in elderly patients particularly closely.
In contrast with younger patients in whom early mitral valve repair is advocated in order to improve life expectancy, very elderly patients are more likely to undergo surgery with the primary aim of improving quality of life, making the likelihood of major morbidity a particularly important factor in the decision whether to operate. Like other groups, we observed a low rate of major post-operative complications during the follow-up period; and low rates of thrombo-embolism, bleeding, and hospitalization for cardiac causes after hospital discharge have been reported elsewhere. 13 Emerging percutaneous techniques may offer a viable alternative to surgery in the large subgroup of elderly patients who present high risk of post-operative morbidity or mortality. Does mitral repair confer a survival advantage over replacement in elderly patients? There is some evidence to suggest that, in contrast with young asymptomatic patients, valve replacement in patients with complex mitral disease pathology, who tend to be older with more co-morbidity and worse ventricular function, may not adversely affect survival compared with mitral valve repair. 23 This non-randomized study does not permit firm conclusions to be drawn regarding how much of the large survival difference between repair and replacement seen at 5 years may be attributed to choice of surgical technique, as factors such as patient frailty and complexity of valve lesion were not included in the propensity analysis. Mitral valve replacement was, however, found to be an independent predictor of mortality in octogenarian patients and associated with decreased survival after propensity score adjustment, which raises questions about the rationale of routine mitral replacement for elderly patients presenting with mitral disease amenable to repair. Feasibility of repair remains a concern for many surgeons, who also believe that repair is associated with longer bypass and crossclamp times, and consequently associated with much poorer outcomes in a patient group likely to be adversely affected by prolonged pump-runs. The repair rate of 70% achieved by surgeons at two centres, with very low rates of residual mitral regurgitation, suggests that these concerns should not preclude a strategy of routine mitral repair in this patient group.
Strengths and limitations
Although this is, to our knowledge, the largest analysis comparing outcomes of mitral valve repair and replacement in octogenarians, this study is a retrospective observational study, and conclusions are limited in their application. We do not have comparative data on patients with mitral valve disease who did not undergo surgery. Clinical outcomes are limited to major post-operative morbidity and mortality, and early echocardiographic results, with no late echocardiographic data or information on late complications, quality of life, or cause of death during follow-up. The repair and replacement groups are heterogeneous, which is only partly addressed by analysing the subgroup of elective patients with isolated degenerative disease, and use of propensity score adjustment.
The main advantages of combining data from two centres are two-fold. First, meaningful subgroup analysis was enhanced by an increase in patient numbers achieved without the loss of detailed data that tends to occur in retrospective registry analyses. Second, these findings may have increased applicability to other similar practices. There are several limitations associated with this approach. First, although it was possible to standardize many variables between participating centres, there are likely to have been differences in patient population and surgical practice that we were unable to account for, and which may have contributed Figure 3 Kaplan-Meier actuarial survival curves comparing outcome of patients according to whether they underwent concomitant coronary artery bypass grafting or not.
Mitral surgery in octogenarians to the fact that institution was one of the strongest independent predictors of repair. Second, there was a significant difference in routine echocardiographic follow-up between institutions, resulting in less than optimal rates of early and mid-term echocardiographic data.
Conclusion
Elective primary isolated mitral valve repair can be performed with low operative mortality and good mid-term outcomes in selected octogenarians with degenerative mitral valve disease, and appears to offer superior early and mid-term survival compared with mitral valve replacement. The survival benefit associated with surgery for mitral regurgitation due to severe ischaemic cardiomyopathy is more questionable, as less than half of these patients were alive 1 year after surgery. Emergency surgery is the strongest independent predictor of mortality in this age group, underlining the desirability of close follow-up and timely operative intervention when indicated. 
